TFX - Teleflex Incorporated
NYSE
->
Healthcare
->
Medical Instruments & Supplies
Wayne,
United States
Type: Equity
TFX price evolution
TFX
| (in millions $) | 31 Dec 2023 | 2 Aug 2023 | 2 May 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $222.85 | $881.5 | $250.82 | $264.14 |
| Short term investments | ||||
| Net receivables | $443.47 | $429.31 | $410.02 | $410.02 |
| Inventory | $626.22 | $631.55 | $614.11 | $614.11 |
| Total current assets | $1407.41 | $1445.8 | $1428.05 | $1428.05 |
| Long term investments | ||||
| Property, plant & equipment | $603.43 | $587.82 | $585.63 | $585.63 |
| Goodwill & intangible assets | $5416.02 | $4708.84 | $4774.08 | $4817.38 |
| Total noncurrent assets | $6125.14 | $5396.36 | $5449.93 | $5489.87 |
| Total investments | ||||
| Total assets | $7532.55 | $6895.73 | $6917.92 | $6917.92 |
| Current liabilities | ||||
| Accounts payable | $132.25 | $142.08 | $136.24 | $136.24 |
| Deferred revenue | ||||
| Short long term debt | $87.5 | $87.5 | $87.5 | $87.5 |
| Total current liabilities | $606.75 | $555.45 | $575.71 | $575.71 |
| Long term debt | $1838.87 | $1470.67 | $1549.47 | $1665.31 |
| Total noncurrent liabilities | $2484.81 | $2594.16 | $2125.18 | $2231.96 |
| Total debt | $1926.37 | $2149.43 | $1670.4 | $1752.81 |
| Total liabilities | $3091.56 | $2680.63 | $2807.67 | $2807.67 |
| Shareholders' equity | ||||
| Retained earnings | $4109.74 | $3973.45 | $3878.08 | |
| Other shareholder equity | -$314.4 | -$381.86 | -$381.33 | |
| Total shareholder equity | $4440.99 | $4314.05 | $4215.09 | $4110.25 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $222.85 | $292.03 | $445.08 | $375.88 |
| Short term investments | ||||
| Net receivables | $443.47 | $408.83 | $383.57 | $395.07 |
| Inventory | $626.22 | $578.51 | $477.64 | $513.2 |
| Total current assets | $1407.41 | $1410.98 | $1429.12 | $1422.42 |
| Long term investments | ||||
| Property, plant & equipment | $603.43 | $578.42 | $573.41 | $574.55 |
| Goodwill & intangible assets | $5416.02 | $4842.9 | $4793.27 | $5105.71 |
| Total noncurrent assets | $6125.14 | $5517.08 | $5442.6 | $5730.13 |
| Total investments | ||||
| Total assets | $7532.55 | $6928.06 | $6871.72 | $7152.56 |
| Current liabilities | ||||
| Accounts payable | $132.25 | $126.81 | $118.24 | $102.52 |
| Deferred revenue | ||||
| Short long term debt | $87.5 | $87.5 | $110 | $100.5 |
| Total current liabilities | $606.75 | $581.49 | $680.12 | $540.03 |
| Long term debt | $1838.87 | $1624.02 | $1856.13 | $2463.99 |
| Total noncurrent liabilities | $2484.81 | $2324.6 | $2436.86 | $3276.07 |
| Total debt | $1926.37 | $1831.96 | $1966.13 | $2564.49 |
| Total liabilities | $3091.56 | $2906.09 | $3116.97 | $3816.1 |
| Shareholders' equity | ||||
| Retained earnings | $4109.74 | $3817.3 | $3517.95 | $3096.23 |
| Other shareholder equity | -$314.4 | -$403.52 | -$346.96 | -$297.3 |
| Total shareholder equity | $4440.99 | $4021.97 | $3754.75 | $3336.46 |
| (in millions $) | 31 Dec 2023 | 2 Aug 2023 | 2 May 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $773.91 | $743.26 | $710.93 | $710.93 |
| Cost of revenue | $342.49 | $319.55 | ||
| Gross Profit | $431.42 | $407.82 | $391.38 | $391.38 |
| Operating activities | ||||
| Research & development | $35.86 | $41.47 | ||
| Selling, general & administrative | $260.65 | $232.72 | ||
| Total operating expenses | $353.4 | $262.75 | $274.18 | $276.41 |
| Operating income | $78.02 | $114.97 | ||
| Income from continuing operations | ||||
| EBIT | $85.69 | $115.27 | ||
| Income tax expense | $28.79 | $15.53 | $20.18 | $20.18 |
| Interest expense | $25.79 | -$16.61 | -$17.49 | $18.34 |
| Net income | ||||
| Net income | $31.11 | $111.33 | $76.75 | $76.75 |
| Income (for common shares) | $31.11 | $76.75 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2974.49 | $2791.04 | $2537.16 | |
| Cost of revenue | $1327.56 | $1259.95 | $1212.28 | |
| Gross Profit | $1646.93 | $1531.09 | $1324.87 | |
| Operating activities | ||||
| Research & development | $154.35 | $153.82 | $119.75 | |
| Selling, general & administrative | $929.87 | $863.75 | $743.57 | |
| Total operating expenses | $1145.07 | $1037.87 | $901.81 | |
| Operating income | $501.87 | $493.22 | $423.07 | |
| Income from continuing operations | ||||
| EBIT | $517.85 | $500.41 | $423.75 | |
| Income tax expense | $76.44 | $83 | $21.93 | |
| Interest expense | $85.08 | $54.26 | $66.49 | |
| Net income | ||||
| Net income | $356.33 | $363.14 | $335.32 | |
| Income (for common shares) | $356.33 | $363.14 | $335.32 | |
| (in millions $) | 31 Dec 2023 | 2 Aug 2023 | 2 May 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $31.11 | $76.75 | ||
| Operating activities | ||||
| Depreciation | $64.2 | $59.83 | ||
| Business acquisitions & disposals | -$588.72 | -$0.06 | ||
| Stock-based compensation | $9.33 | $7.01 | ||
| Total cash flows from operations | $138.86 | $84.06 | ||
| Investing activities | ||||
| Capital expenditures | -$27.67 | -$21.84 | ||
| Investments | $52.86 | |||
| Total cash flows from investing | -$563.53 | -$29.23 | -$21.9 | -$21.9 |
| Financing activities | ||||
| Dividends paid | -$15.98 | -$31.94 | -$15.97 | -$15.97 |
| Sale and purchase of stock | $4.66 | -$2.43 | ||
| Net borrowings | -$223.13 | -$75.13 | ||
| Total cash flows from financing | -$237.5 | -$185.99 | -$93.59 | -$93.59 |
| Effect of exchange rate | $3.52 | $3.84 | $3.53 | $3.53 |
| Change in cash and equivalents | -$658.65 | -$41.22 | -$27.9 | -$27.9 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $356.33 | $363.14 | $485.37 | $335.32 |
| Operating activities | ||||
| Depreciation | $242.12 | $230.59 | $237.36 | $227.25 |
| Business acquisitions & disposals | -$588.92 | -$186 | $220.32 | -$766.43 |
| Stock-based compensation | $31.46 | $27.22 | $22.94 | $20.74 |
| Total cash flows from operations | $510.64 | $342.14 | $651.42 | $436.41 |
| Investing activities | ||||
| Capital expenditures | -$91.44 | -$79.19 | -$71.62 | -$90.69 |
| Investments | $59.13 | $5.78 | $8.04 | $19.34 |
| Total cash flows from investing | -$621.23 | -$257.94 | $156.74 | -$837.78 |
| Financing activities | ||||
| Dividends paid | -$63.9 | -$63.79 | -$63.65 | -$63.22 |
| Sale and purchase of stock | $5.19 | -$4.31 | $23.55 | $18.99 |
| Net borrowings | $101.25 | -$140.25 | -$634.5 | $575 |
| Total cash flows from financing | $38.54 | -$217.51 | -$715.82 | $455.16 |
| Effect of exchange rate | $2.86 | -$19.74 | -$23.13 | $21.01 |
| Change in cash and equivalents | -$69.19 | -$153.05 | $69.2 | $74.8 |
News
Fundamentals
| Market cap | $9.91B |
|---|---|
| Enterprise value | $11.61B |
| Shares outstanding | 47.04M |
| Revenue | $2.94B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $295.94M |
| Revenue Q/Q | 2.10% |
| Revenue Y/Y | 5.30% |
| P/E ratio | 33.49 |
|---|---|
| EV/Sales | 3.95 |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 3.37 |
| P/B ratio | 2.08 |
| Book/Share | 101.09 |
| Cash/Share | 4.74 |
| EPS | $6.29 |
|---|---|
| ROA | 4.19% |
| ROE | 6.93% |
| Debt/Equity | 0.70 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.32 |
| Quick ratio | 1.29 |